Answers are grounded in this paper and cite their sources.
Network meta-analysis reveals superior ACR responses and comparable tolerability for JAK inhibitors versus placebo in rheumatoid arthritis, supporting their clinical utility.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Almoallim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: